Latest Medical News from Russia

For the 9 months of 2025 compared to the same period in 2024, Russia's Ministry of Health recorded 25% growth in the financial volume of medical care provided to foreign citizens. The volume of treatment for patients with serious oncological, cardiological, and ophthalmological conditions increased particularly notably.

Thanks to government and private investment, Russia has created comprehensive nuclear medicine infrastructure over the past 20 years, a network of PET/CT diagnostic centers, SPECT/CT facilities at major multidisciplinary clinics, and "hot beds" for radiopharmaceutical treatment. This infrastructure is followed by radiopharmaceutical development and clinical trials, and theranostics development available in only a few countries. Read the full analysis on Marus Media.

For blood cancers that don't respond well to standard treatments, oncologists and hematologists are turning to the personalized CAR-T approach (chimeric antigen receptor T-cell therapy). This treatment creates modified T-cells from a patient's own cells that can destroy tumor cells. This overview from Marus Media provides the current status of the technology and its availability for medical tourists.

It is located on Glukharskaya Street adjacent to the existing MIBS Proton Therapy Center. Together they form a full-cycle oncology cluster, from diagnostics and surgical treatment to systemic and radiation therapy.

Modern embryology is a field of reproductive medicine where technological innovations directly determine clinical outcomes. Alexander Vysotsky, Head of the Embryological Laboratory of the Lebedeva Center for Innovative Reproductive Technologies at the Mother and Child Group Clinical Hospital, spoke about the development of Russian embryology for Marus Media.

For World Asthma Day, Marus Media explores how life has changed for patients with this diagnosis. Not long ago, asthma meant uncontrolled exacerbations, poorly managed conditions, and frequent hospitalizations. Today, it's long-term symptom control, personalized therapy, and the ability to live without limitations.

Russia's Ministry of Health has approved a clinical trial of the innovative targeted drug OM-RCA-01 for treating metastatic cancer. Trials are underway in six Russian cities. According to Marus Media, international patients can participate in the clinical trial, including those from BRICS and CIS countries.

Russian President Vladimir Putin has approved the country's Healthcare Development Strategy through 2030. The document establishes priorities for developing promising medical technologies. The list includes personalized and cellular products (including CAR-T therapy), bioprinting and tissue engineering, radiopharmaceuticals for nuclear medicine, genetic technologies, neuroprosthetics, and artificial intelligence-based systems.

Ramiclinic Residence has opened on Krestovsky Island in St. Petersburg, a clinic combining aesthetic medicine with luxury-class service. The project develops the "medical residence" concept, where patients can receive a comprehensive solution, from diagnosis and surgery to rehabilitation, in one place. Breast oncologist, plastic surgeon, and Deputy Chief Medical Officer of Ramiclinic Residence Anton Telishevsky discusses the business model, safety principles, and medical expertise.